| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,573 |
16,450 |
$904K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,037 |
2,607 |
$206K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,941 |
2,239 |
$68K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,545 |
2,092 |
$65K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,012 |
922 |
$62K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,225 |
3,677 |
$52K |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,916 |
1,636 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
571 |
475 |
$13K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
109 |
105 |
$4K |
| 87807 |
|
218 |
157 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
562 |
508 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$958.85 |
| 81003 |
|
351 |
301 |
$547.22 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
63 |
56 |
$539.58 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18 |
15 |
$360.08 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18 |
14 |
$194.48 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
30 |
26 |
$1.53 |